ReviewSensors (Basel, Switzerland)2025
Optical Non-Invasive Glucose Monitoring Using Aqueous Humor: A Review.
Review in Sensors (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
This review explores optical technologies for non-invasive glucose monitoring (NIGM) using aqueous humor (AH) as media, addressing the limitations of traditional invasive methods in diabetes management. It analyzes key techniques such as Raman spectroscopy, polarimetry, and mid- and near-infrared spectral methods, highlighting their respective challenges, alongside emerging hybrid approaches like photoacoustic spectroscopy and optical coherence tomography. Crucially, the practical realization of these optical methods for portable NIGM hinges on advanced instrumentation. Therefore, this review also details progress in compact NIR spectrometers. While conventional systems often lack suitability, significant advancements in on-chip technologies-including miniaturized dispersive spectrometers and various on-chip Fourier transform systems (e.g., spatial heterodyne, stationary wave integral, and temporally modulated FT systems)-utilizing integration platforms like SOI and SiN are promising. Such innovations offer the potential for high spectral resolution, large bandwidth, and miniaturization, which are essential for developing practical AH-based NIGM systems to improve diabetes care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.